We now know that cancer is many different diseases, with great variation even within a
single histological subtype. With the current emphasis on developing personalized …

Vascular endothelial growth factor (VEGF) is one of the most important inducers of
angiogenesis, therefore blocking angiogenesis has led to great promise in the treatment of …

BPC 157, a pentadecapeptide with extensive healing effects, has recently been suggested
to contribute to angiogenesis. However, the underlying mechanism is not yet clear. The …

Background Mesenchymal stromal/stem cells derived from human umbilical cord (UC-
MSCs) uniquely combine properties of embryonic and postnatal MSCs and may be the most …

The ability to control vascular endothelial growth factor (VEGF) signaling offers promising
therapeutic potential for vascular diseases and cancer. Despite this promise, VEGF-targeted …

Recent research offers several approaches for the advancement of manganese‐based
nanomaterials for its therapeutic use. The present research paper reports the development …

Physics-based computational models of the cardiovascular system are increasingly used to
simulate hemodynamics, tissue mechanics, and physiology in evolving healthy and …

Capillaries, which are the smallest and most abundant type of blood vessel, form the primary
site of gas, nutrient, and waste transfer between the vascular and tissue compartments …

Plasma membrane‐localized vascular endothelial growth factor receptors (VEGFR) play a
critical role in transducing VEGF signaling toward pro and antiangiogenic outcomes and …

Dysregulation of tyrosine kinase receptor (RTK) signaling pathways play important roles in
glioblastoma (GBM). However, therapies targeting these signaling pathways have not been …